Quince Therapeutics
QNCX
QNCX
88 hedge funds and large institutions have $99.5M invested in Quince Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
35% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 34
54% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 24
59% less capital invested
Capital invested by funds: $241M → $99.5M (-$142M)
Holders
88
Holding in Top 10
1
Calls
$4.92M
Puts
$5.54M
Top Buyers
| 1 | +$3.59M | |
| 2 | +$1.9M | |
| 3 | +$1.74M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$924K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$647K |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$3.1M | |
| 3 | -$2.19M | |
| 4 |
Walleye Capital
New York
|
-$1.73M |
| 5 |
Morgan Stanley
New York
|
-$1.34M |